These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26992738)

  • 21. Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models.
    Tamada T; Prabhu V; Li J; Babb JS; Taneja SS; Rosenkrantz AB
    Radiology; 2017 Jul; 284(1):100-108. PubMed ID: 28394755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computed diffusion-weighted magnetic resonance imaging with high b-values in the diagnosis of gallbladder lesions.
    Sato M; Kurita Y; Sakai E; Watanabe S; Sanada H; Shimizu T; Kanoshima K; Takai Y; Meguro K; Sugimoto Y; Biwata Y; Hosono K; Kobayashi N; Kubota K; Nakajima A
    Abdom Radiol (NY); 2022 Sep; 47(9):3278-3289. PubMed ID: 35767024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.
    Maas MC; Fütterer JJ; Scheenen TW
    Invest Radiol; 2013 Nov; 48(11):779-86. PubMed ID: 23907102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
    Kim CK; Park BK; Kim B
    AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conspicuity of peripheral zone prostate cancer on computed diffusion-weighted imaging: comparison of cDWI1500, cDWI2000, and cDWI3000.
    Vural M; Ertaş G; Onay A; Acar Ö; Esen T; Sağlıcan Y; Zengingönül HP; Akpek S
    Biomed Res Int; 2014; 2014():768291. PubMed ID: 25525603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Image quality and diagnostic accuracy of complex-averaged high b value images in diffusion-weighted MRI of prostate cancer.
    Kordbacheh H; Seethamraju RT; Weiland E; Kiefer B; Nickel MD; Chulroek T; Cecconi M; Baliyan V; Harisinghani MG
    Abdom Radiol (NY); 2019 Jun; 44(6):2244-2253. PubMed ID: 30838425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of different mathematical models and different b-value ranges of diffusion-weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm2.
    Feng Z; Min X; Margolis DJ; Duan C; Chen Y; Sah VK; Chaudhary N; Li B; Ke Z; Zhang P; Wang L
    PLoS One; 2017; 12(2):e0172127. PubMed ID: 28199367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
    Waseda Y; Yoshida S; Takahara T; Kwee TC; Matsuoka Y; Saito K; Kihara K; Fujii Y
    J Magn Reson Imaging; 2017 Aug; 46(2):490-496. PubMed ID: 28152258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).
    Kitajima K; Takahashi S; Ueno Y; Yoshikawa T; Ohno Y; Obara M; Miyake H; Fujisawa M; Sugimura K
    J Magn Reson Imaging; 2012 Jul; 36(1):198-205. PubMed ID: 22371381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of different computed high b-values on diffusion weighted imaging scores in Prostate Imaging Reporting and Data System version 2 of prostate cancer in peripheral zone].
    Wang W; Shao ZH; Zeng JQ; Wu DL; Wang GL; Wang PJ
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(43):3401-3405. PubMed ID: 29179281
    [No Abstract]   [Full Text] [Related]  

  • 33. Diffusion-weighted magnetic resonance imaging for the evaluation of prostate cancer: optimal B value at 3T.
    Koo JH; Kim CK; Choi D; Park BK; Kwon GY; Kim B
    Korean J Radiol; 2013; 14(1):61-9. PubMed ID: 23323032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
    Park SY; Kim CK; Park BK; Kwon GY
    AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    Krishna S; Lim CS; McInnes MDF; Flood TA; Shabana WM; Lim RS; Schieda N
    J Magn Reson Imaging; 2018 Jan; 47(1):176-185. PubMed ID: 28387981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion-weighted imaging of prostate cancer: effect of b-value distribution on repeatability and cancer characterization.
    Merisaari H; Toivonen J; Pesola M; Taimen P; Boström PJ; Pahikkala T; Aronen HJ; Jambor I
    Magn Reson Imaging; 2015 Dec; 33(10):1212-1218. PubMed ID: 26220861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
    Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
    Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis.
    Wetter A; Nensa F; Lipponer C; Guberina N; Olbricht T; Schenck M; Schlosser TW; Gratz M; Lauenstein TC
    Acta Radiol; 2015 Aug; 56(8):1009-15. PubMed ID: 25168023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting.
    Mazaheri Y; Vargas HA; Akin O; Goldman DA; Hricak H
    J Magn Reson Imaging; 2012 Mar; 35(3):660-8. PubMed ID: 22069141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.
    Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M
    Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.